Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franzese

Showing results (601-610 of 1,043) with videos related to

Pageof 105
Sort By:
Diabetes Research and Clinical Practice|August 7, 2022
The impact of gluten-free diet on growth, metabolic control and quality of life in youth with type 1 diabetes and celiac disease: A systematic reviewEnza Mozzillo, Roberto Franceschi, Francesca Di Candia, et al.
World Neurosurgery|April 25, 2021
Changing Enhancement Pattern and Tumor Volume of Vestibular Schwannomas After Subtotal ResectionRobert S Heller, Hadi Joud, Gabriel Flores-Milan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 11, 2019
Predictive Factors for Response and Survival in a Cohort of Oligometastatic Patients Treated With Stereotactic Body Radiation TherapyDavide Franceschini, Fiorenza De Rose, Ciro Franzese, et al.
Cancer Research and Treatment|April 29, 2016
Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to SurgeryCiro Franzese, Davide Franceschini, Luca Cozzi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 12, 2018
Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapyCiro Franzese, Tiziana Comito, Eno Toska, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 22, 2025
Development of a Joint Tumor Size-Overall Survival Modeling and Simulation Framework Supporting Oncology Development Decision-MakingHerbert Struemper, Chetan Rathi, Morris Muliaditan, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 13, 2019
Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factorsElena Clerici, Tiziana Comito, Ciro Franzese, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 22, 2025
Tutorial on Conditional Simulations With a Tumor Size-Overall Survival Model to Support Oncology Drug DevelopmentSebastiaan C Goulooze, Morris Muliaditan, Richard C Franzese, et al.
Clinical Science (London, England : 1979)|November 1, 1986
Intracellular ion metabolism in erythrocytes and uraemia: the effect of different dialysis treatmentsM Trevisan, N De Santo, M Laurenzi, et al.
The Prostate|December 19, 2023
Long term update on toxicity and survival of a phase II trial of linac-based stereotactic body radiation therapy for low-intermediate risk prostate cancerGiuseppe R D'Agostino, Marco Badalamenti, Sara Stefanini, et al.
Pageof 105

Showing results (601-610 of 1,043) with videos related to

Sort By:
Pageof 105
Diabetes Research and Clinical Practice|August 7, 2022
The impact of gluten-free diet on growth, metabolic control and quality of life in youth with type 1 diabetes and celiac disease: A systematic reviewEnza Mozzillo, Roberto Franceschi, Francesca Di Candia, et al.
World Neurosurgery|April 25, 2021
Changing Enhancement Pattern and Tumor Volume of Vestibular Schwannomas After Subtotal ResectionRobert S Heller, Hadi Joud, Gabriel Flores-Milan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 11, 2019
Predictive Factors for Response and Survival in a Cohort of Oligometastatic Patients Treated With Stereotactic Body Radiation TherapyDavide Franceschini, Fiorenza De Rose, Ciro Franzese, et al.
Cancer Research and Treatment|April 29, 2016
Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to SurgeryCiro Franzese, Davide Franceschini, Luca Cozzi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 12, 2018
Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapyCiro Franzese, Tiziana Comito, Eno Toska, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 22, 2025
Development of a Joint Tumor Size-Overall Survival Modeling and Simulation Framework Supporting Oncology Development Decision-MakingHerbert Struemper, Chetan Rathi, Morris Muliaditan, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 13, 2019
Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factorsElena Clerici, Tiziana Comito, Ciro Franzese, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 22, 2025
Tutorial on Conditional Simulations With a Tumor Size-Overall Survival Model to Support Oncology Drug DevelopmentSebastiaan C Goulooze, Morris Muliaditan, Richard C Franzese, et al.
Clinical Science (London, England : 1979)|November 1, 1986
Intracellular ion metabolism in erythrocytes and uraemia: the effect of different dialysis treatmentsM Trevisan, N De Santo, M Laurenzi, et al.
The Prostate|December 19, 2023
Long term update on toxicity and survival of a phase II trial of linac-based stereotactic body radiation therapy for low-intermediate risk prostate cancerGiuseppe R D'Agostino, Marco Badalamenti, Sara Stefanini, et al.
Pageof 105